| Treatment Approaches for MOG-Ab-Associated Demyelination in Children |
28 |
| Gastrointestinal Dysfunction in Parkinson's Disease |
16 |
| Current Treatment Options in NeurologySMA Therapeutics |
12 |
| Treatment of Tuberculous Meningitis and Its Complications in Adults |
12 |
| Treatment of Persistent Postural-Perceptual Dizziness (PPPD) and Related Disorders |
11 |
| Current Status of Antiepileptic Drugs as Preventive Migraine Therapy |
11 |
| Disease-Modifying Treatment in Progressive Multiple Sclerosis |
10 |
| Current and Emerging Therapies for Duchenne Muscular Dystrophy |
10 |
| Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment |
10 |
| Stereotactic Radiosurgery for Multiple Brain Metastases |
10 |
| Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis |
9 |
| Congenital Myasthenic Syndromes: a Clinical and Treatment Approach |
8 |
| Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials |
8 |
| Current Treatment Strategies and Future Treatment Options for Dravet Syndrome |
8 |
| Reducing the Risk of Sudden Unexpected Death in Epilepsy (SUDEP) |
7 |
| Botulinum Toxin Treatment of Movement Disorders |
7 |
| Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation |
7 |
| Beta-Blockers for Migraine Prevention: a Review Article |
6 |
| Treatment of Extracranial Arterial Dissection: the Roles of Antiplatelet Agents, Anticoagulants, and Stenting |
6 |
| The Comprehensive Management of Cerebellar Ataxia in Adults |
6 |
| Risk Factors for Sudden Unexpected Death in Epilepsy (SUDEP) and Their Mitigation |
6 |
| Sleep Abnormalities in Multiple Sclerosis |
6 |
| The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review |
6 |
| Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis? |
5 |
| Complementary and Alternative Medicine for Painful Peripheral Neuropathy |
5 |
| Antidepressants for Preventive Treatment of Migraine |
5 |
| Quo Vadis-Do Immunotherapies Have a Role in Glioblastoma? |
5 |
| Approaches to Remyelination Therapies in Multiple Sclerosis |
5 |
| Statins in Ischemic Stroke Prevention: What Have We Learned in the Post-SPARCL (The Stroke Prevention by Aggressive Reduction in Cholesterol Levels) Decade? |
5 |
| Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease |
5 |
| Restless Legs Syndrome and Other Movement Disorders of SleepTreatment Update |
5 |
| Update on Trigeminal Neuralgia |
5 |
| Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS |
5 |
| Pediatric Neuromyelitis Optica Spectrum Disorders |
5 |
| Pain Management in Multiple Sclerosis: a Review of Available Treatment Options |
4 |
| Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas |
4 |
| An Update on the Treatment of Chorea |
4 |
| Exploring Wellness Interventions in Progressive Multiple Sclerosis: an Evidence-Based Review |
4 |
| Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors |
4 |
| The Assessment and Management of Peripheral Nerve Trauma |
4 |
| Anti-IgLON 5 Disease |
4 |
| Treatment Options for Agitation in Dementia |
4 |
| Cryopyrin-Associated Periodic Fever Syndrome and the Nervous System |
4 |
| Treatment of Post-Stroke Depression |
4 |
| The Role of Surgery in Meningiomas |
4 |
| Headache and Its Management in Patients With Multiple Sclerosis |
4 |
| Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management |
3 |
| Orthostatic Tremor: Pathophysiology Guiding Treatment |
3 |
| Novel Systemic Treatments for Brain Metastases From Lung Cancer |
3 |
| Diagnosis and Management of Autonomic Dysfunction in Dementia Syndromes |
3 |
